Engineered T cells for the Treatment of Malignancy

Time: 11:40 am
day: Focus Day

Details:

• Challenges with current therapeutic modalities, and why engineered T cell therapeutics are an attractive option
• Challenges and improvements to in silico based prediction methods for selecting epitopes for generating TCRs against
• Current strategy for selecting epitopes for engineering T cells against using a combination of biochemical and mass spectrometric
approaches

Speakers: